Patents by Inventor James Kelly

James Kelly has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250114566
    Abstract: System for endocardial injection are disclosed. An example system may include a first steerable catheter having a first lumen formed therein. A second steerable catheter may be disposed within the first lumen. The second steerable catheter may have a second lumen formed therein. An injection catheter may be disposed within the second lumen. The injection catheter may have a distal end region. The distal end region may include an imaging section and a needle section. The system may include an imaging device configured to be disposed within the imaging section.
    Type: Application
    Filed: October 3, 2024
    Publication date: April 10, 2025
    Applicant: Boston Scientific Scimed, Inc.
    Inventors: Aiden Flanagan, Martyn G. Folan, Tim O'Connor, Jonathan Heelan, Martin Lawrence Fawdry, Michael Hughes, Michael James Kelly
  • Patent number: 12262962
    Abstract: Systems and methods for providing orientation data to a user during a medical procedure performed on a subject are provided. The system can include a medical device, an electrical component and a display device. The medical device is configured to engage a portion the subject and includes a handle. The electrical component is disposed within the handle and is configured to generate data related to an orientation of the medical device during the medical procedure. The display device is physically separate from the medical device and in communication the electrical component. The display device also includes a processor configured to receive and process the data related to the orientation of the medical device, and display information related to the orientation of the medical device to the user based on the data.
    Type: Grant
    Filed: February 27, 2018
    Date of Patent: April 1, 2025
    Assignees: Dignity Health, Arizona Board of Regents on Behalf of Arizona State University
    Inventors: Brian Kelly, Anna Newcomb, William Langenbach, Kirsten Jefferys, Luis Manuel Tumialan, James Abbas
  • Patent number: 12260157
    Abstract: Systems and methods for calibrating and initializing a system comprising a first qubit, a second qubit, and a coupler are provided. A method of initializing the system can include calibrating the system; providing a first idle resonance frequency of the first qubit and a second idle resonance frequency of the second qubit; providing the first bias for the first idle resonance frequency and the second bias for the second idle resonance frequency; determining a value of the third resonance frequency at which a difference between the first degree of coupling and the second degree of coupling is minimized, when the first resonance frequency is the first idle resonance frequency and the second resonance frequency is the second idle resonance frequency; and providing the third bias according to the determined value of the third resonance frequency.
    Type: Grant
    Filed: December 2, 2020
    Date of Patent: March 25, 2025
    Assignee: GOOGLE LLC
    Inventors: Kevin Joseph Satzinger, Andrew Lorne Dunsworth, Kostyantyn Yevgenovych Kechedzhi, Julian Shaw Kelly, Charles James Neill, Pedram Roushan
  • Patent number: 12258339
    Abstract: The present technology provides compounds as well as compositions including such compounds useful in targeted radiotherapy of cancer and/or mammalian tissue overexpressing prostate specific membrane antigen (“PSMA”) where the compounds are represented by the following: or a pharmaceutically acceptable salt thereof, or a pharmaceutically acceptable salt thereof, or a pharmaceutically acceptable salt thereof, wherein M1 is independently at each occurrence an alpha-emitting radionuclide. Equivalents of such compounds are also disclosed.
    Type: Grant
    Filed: February 23, 2022
    Date of Patent: March 25, 2025
    Assignee: Cornell University
    Inventors: John W. Babich, Justin Wilson, Nikki Thiele, James Kelly, Shashikanth Ponnala
  • Patent number: 12242114
    Abstract: A multimode optical waveguide network comprises a parent waveguide and a plurality of child waveguides. Each waveguide is a multimode optical waveguide having a first surface region, multiple second surface regions, and at least one guiding element attached to a surface of the waveguide or embedded within the waveguide, each second surface region of the parent waveguide optically coupled to the first surface region of a corresponding child waveguide. The guiding element(s) of the parent waveguide is arranged to guide a beam, from or to its first surface region, to or from any selected second surface region of its multiple second surface regions. The guiding element(s) of each of the waveguides is configurable for selecting the second surface region of that waveguide and/or responsive to at least one beam characteristic for selecting the second surface region of that waveguide via modulation of the at least one beam characteristic.
    Type: Grant
    Filed: February 22, 2021
    Date of Patent: March 4, 2025
    Assignee: Microsoft Technology Licensing, LLC
    Inventors: Douglas James Kelly, Benn Charles Thomsen, Dushyanth Narayanan, Antony Ian Taylor Rowstron, Andreas Georgiou
  • Patent number: 12239341
    Abstract: A tissue-removing catheter for removing tissue in a body lumen includes an elongate body having an axis. A handle is mounted to a proximal end portion of the elongate body. A tissue-removing element is mounted on a distal end portion of the elongate body. An inner liner is received within the elongate body and defines a guidewire lumen. An advancer is mounted on the handle and is movable relative to the housing. The inner liner is coupled to the advancer at a proximal end portion of the inner liner such that movement of the advancer causes a corresponding movement of the inner liner to exert a push force on the tissue-removing element to advance the tissue-removing element and a pull force on the tissue-removing element to retract the tissue-removing element for moving the tissue-removing element relative to the handle.
    Type: Grant
    Filed: March 9, 2022
    Date of Patent: March 4, 2025
    Assignee: MEDTRONIC VASCULAR, INC.
    Inventors: Rebecca Marie Helebert, Thomas P. Hayden, Aram Jamous, Conor McMullen, Tomas K. Kelly, Michael James Donegan, Eoin J. Walsh, Aran Murray
  • Publication number: 20250064121
    Abstract: Provided is a vapour generating system with a heatable ceramic wick (300) for vaporizing a liquid. The wick (300) has an aerofoil shape to provide laminar air flow over the wick (300).
    Type: Application
    Filed: December 16, 2022
    Publication date: February 27, 2025
    Inventors: Matthew Pilkington, Phillip Taylor, Alexander Edwards, Jonathan Davies, Benjamin Illidge, James Keefe, Conor Kelly, Carlos Fabrellas-Garcia
  • Publication number: 20250069075
    Abstract: Wireless communication technologies, a dynamic transaction card, and a mobile application may be utilized to facilitate multi-factor authentication and secure electronic checkout of any website. A wireless connection between a dynamic transaction card and a user device may be utilized to authenticate a user. A user device application may be triggered to call, via an application programming interface (API), an account provider system, and this unique pairing may automatically facilitate payment to a merchant system associated with the electronic check out page.
    Type: Application
    Filed: November 12, 2024
    Publication date: February 27, 2025
    Inventors: James Zarakas, Mohamed Lafeer, Molly Johnson, Saleem Sangi, Kevin Kelly, Adam Koeppel
  • Patent number: 12238110
    Abstract: Embodiments of the disclosure are directed to methods, apparatuses, computer-readable media, and systems for network monitoring of communication requests for authorization to an access device. One embodiment is directed at dual message model in a distributed environment with an electronic access device receiving a cancellation signal and generating and sending a reversal message with cancellation information embedded in the data elements of the reversal message to a processor computer, where the cancellation data may be read and saved by the processor computer before the authorization request message is forwarded to be authorized by an authorization entity. The method further comprises generating a cancellation message after the reversal message has processed, where the cancellation message is sent via a transport computer to clear and reconcile the authorization status of the cancelled authorization request with any necessary authorizing or regulatory entities in the network.
    Type: Grant
    Filed: December 18, 2019
    Date of Patent: February 25, 2025
    Assignee: Visa International Service Association
    Inventors: Paul Teague, Lee James Kelly
  • Publication number: 20250041882
    Abstract: An electrostatic atomizer electrostatically atomizes a fluid into a charged spray, wherein the charged spray includes a plurality of charged droplets. The electrostatic atomizer includes a chamber forming an inlet and an exit aperture, wherein the chamber is configured for fluid to flow into the chamber from the inlet and to flow out of the chamber from the aperture. An emitter electrode is in liquid contact with the fluid in the chamber and injects an electrical charge into the fluid in the chamber. An impedance circuit is coupled to the chamber and configured to obtain a voltage difference between the emitter electrode and the exit aperture, wherein the voltage difference is at least a minimum voltage threshold.
    Type: Application
    Filed: February 8, 2024
    Publication date: February 6, 2025
    Applicant: FouRy, Inc.
    Inventor: Arnold James Kelly
  • Patent number: 12187090
    Abstract: A control system (300) configured to control an active suspension system (104) of a vehicle (100), the control system comprising one or more controller (301), wherein the control system is configured to: determine (702) that the vehicle is travelling on or approaching repeating surface undulations; determine (709) vehicle speed; determine (708) an indication of surface wavelength of the repeating surface undulations; and control (722, 728) the active suspension system to control at least one of a leading wheel suspension frequency and a trailing wheel suspension frequency in dependence on the vehicle speed and surface wavelength.
    Type: Grant
    Filed: November 25, 2021
    Date of Patent: January 7, 2025
    Assignee: Jaguar Land Rover Limited
    Inventors: Elliot Hemes, Luke Birch, Dennis Lausecker, James Kelly, Syed Asad Ali
  • Publication number: 20240402750
    Abstract: An optical projection system is described that may be used in an optical computing element. The optical projection system has an optical axis and comprises first, second and third lens arrangements. The first and third lens arrangements are rotationally symmetric about the optical axis and are positioned to capture light from an array of sources on a source plane and image the sources onto an output plane. The second lens arrangement is positioned between the first and third lens arrangements. The second lens arrangement has optical power of a first magnitude in a first orientation and optical power of a second magnitude in a second orientation, wherein the first magnitude is larger than the second magnitude and wherein the first orientation is orthogonal to the second orientation and both the first and second orientations are orthogonal to the optical axis.
    Type: Application
    Filed: May 31, 2023
    Publication date: December 5, 2024
    Inventors: James Hilton CLEGG, Douglas James KELLY, Francesca PARMIGIANI, Grace BRENNAN, Jiaqi CHU, Lucinda Michelle PICKUP, Hitesh BALLANI
  • Patent number: 12154436
    Abstract: Methods and apparatus for controlling two or more vehicles travelling in formation. Selected vehicles may be fully or partially autonomously controlled; at least one vehicle is partially controlled by a human driver. Information is collected at each vehicle and from the drivers and it is shared with other vehicles and drivers to create a shared world model. Aspects of the shared world model may be presented to the human driver, who may then respond with a control input. Autonomy systems and the drivers on the vehicles then collaborate to make a collective decision to act or not to act and execute any such action in a coordinated manner.
    Type: Grant
    Filed: November 17, 2021
    Date of Patent: November 26, 2024
    Assignee: Stack AV Co.
    Inventors: Tekin Alp Meriçli, Venkataramanan Rajagopalan, Michael David George, Cetin Alp Meriçli, Alonzo James Kelly, Nezih Ergin Ozkucur, Charles Brian Erny, Craig Eugene Eyth, Dennis Jeffrey Hoff
  • Publication number: 20240382572
    Abstract: The present disclosure arises at least in part from the seminal recognition that a combination treatment regimen including one or more cycles and/or doses of a checkpoint inhibitor and a therapeutic, either sequentially, in either order, or substantially simultaneously, can be more effective in treating cancer in some subjects and/or can initiate, enable, increase, enhance or prolong the activity and/or number of immune cells, or a medically beneficial response by a tumor.
    Type: Application
    Filed: March 25, 2024
    Publication date: November 21, 2024
    Applicants: Cognate Bioservices, Inc., Northwest Biotherapeutics, Inc., The Regents of the University of California, RevImmune, Inc.
    Inventors: Marnix Leo Bosch, James Kelly Ganjei, Linda F. Powers, Linda M. Liau, Robert M. Prins
  • Publication number: 20240366394
    Abstract: Embodiments of the present invention include a convertible prosthesis that is capable of conversion from a humeral head replacement to a reverse reconstruction without any removal of parts integrated into the patient's bony anatomy (e.g. implant stems). A desired overall implant inclination angle may be achieved by matching various implant stems with various reverse inserts, thus permitting a resection surface to be matched with an implant stem selection while also permitting a desired overall implant inclination angle to be achieved through the selection of an appropriate insert.
    Type: Application
    Filed: July 15, 2024
    Publication date: November 7, 2024
    Applicant: STRYKER EUROPEAN OPERATIONS LIMITED
    Inventors: Pierric DERANSART, Vincent GABORIT, Brian MARONEY, Brian C. HODOREK, Shawn M. GARGAC, Pascal BOILEAU, Gilles WALCH, Luc FAVARD, Philippe CLAVERT, François SIRVEAUX, James KELLY, Sumant KRISHNAN, Daniel MOLE, Cédric COMTE, Eric RUNDSTADLER, François MONDI, Christopher R. CHUINARD, Thomas Bradley EDWARDS
  • Publication number: 20240358807
    Abstract: A combination treatment regimen including one or more cycles and/or doses of a checkpoint inhibitor and a therapeutic, either sequentially, in either order, or substantially simultaneously, can be more effective in treating cancer in some subjects and/or can initiate, enable, increase, enhance or prolong the activity and/or number of immune cells, the efficacy of anti-tumor immune responses or a medically beneficial response by a tumor.
    Type: Application
    Filed: October 18, 2023
    Publication date: October 31, 2024
    Applicants: Cognate Bioservices, Inc., Northwest Biotherapeutics, Inc., The Regents of the University of California, RevImmune, Inc.
    Inventors: Marnix Leo Bosch, James Kelly Ganjei, Linda F. Powers, Linda M. Liau, Robert M. Prins
  • Publication number: 20240330761
    Abstract: A process for facilitating environmental conservation is described.
    Type: Application
    Filed: August 1, 2022
    Publication date: October 3, 2024
    Applicant: CONSERVATION X LABS, INC.
    Inventors: Samuel James Kelly, Chad Stephen Gallinat, Henrik Thomas Oftedahl Cox, Patrict Edward Charles COME, Paul BUNJE, Alex DEHGAN
  • Patent number: 12103922
    Abstract: The present technology provides compounds as well as compositions including such compounds useful in targeted radiotherapy of cancer and/or mammalian tissue overexpressing prostate specific membrane antigen (“PSMA”) where the compounds are represented by the following: or a pharmaceutical y acceptable salt thereof, or a pharmaceutically acceptable salt thereof, or a pharmaceutically acceptable salt thereof, wherein M1 is independently at each occurrence an alpha-emitting radionuclide. Equivalents of such compounds are also disclosed.
    Type: Grant
    Filed: February 23, 2022
    Date of Patent: October 1, 2024
    Assignee: CORNELL UNIVERSITY
    Inventors: John W. Babich, Justin Wilson, Nikki Thiele, James Kelly, Shashikanth Ponnala
  • Publication number: 20240304216
    Abstract: In an optical data transfer system, a beam modulator is configured to embed a set of data in an input beam. A multimode optical waveguide network has an in-coupling region for receiving the input beam. The multimode optical waveguide network is configured to guide the input beam to an out-coupling region of the multimode optical waveguide network. A spatial coherent detector is configured to measure a phase and an amplitude of an output optical field at multiple locations. The output optical field is at least partially defined by the input beam and thus exhibiting distortion effects caused by the passage of the beam through the multimode waveguide network. Signal processing is applied to an output of the spatial coherent detector, in order to compensate for the distortion effects, and thereby recover, from the output of the spatial coherent detector, the set of data embedded in the input beam.
    Type: Application
    Filed: April 15, 2024
    Publication date: September 12, 2024
    Inventors: Douglas James KELLY, Benn Charles THOMSEN, Dushyanth NARAYANAN, Antony Ian Taylor ROWSTRON
  • Patent number: D1062104
    Type: Grant
    Filed: January 17, 2022
    Date of Patent: February 11, 2025
    Assignee: Dog Day Design Ltd.
    Inventors: Diarmuid Kelly, James McIlvenna